1-4 of 4
Chi Zhang
Close
Sort by
Journal Articles

C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma

Clinical Trials & Observations
Coty Hing Yau Cheung, Chi Keung Cheng, Kam Tong Leung, Chi Zhang, Chi Yan Ho, Xi Luo, Angel Yuet Fong Kam, Tian Xia, Thomas Shek Kong Wan, Herbert Augustus Pitts, Natalie Pui Ha Chan, Joyce Sin Cheung, Raymond Siu Ming Wong, Xiao-Bing Zhang, Margaret Heung Ling Ng
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2217–2234.
https://doi.org/10.1182/bloodadvances.2023010218
Published: 2024
Includes: Supplemental data
Journal Articles

R4 RGS proteins suppress engraftment of human hematopoietic stem/progenitor cells by modulating SDF-1/CXCR4 signaling

Kathy Yuen Yee Chan, Chi Zhang, Yorky Tsin Sik Wong, Xiao-Bing Zhang, Chi Chiu Wang, Wing Hei Ng, Siu Ping Fok, Patrick Ming Kuen Tang, Wei Kang, Bo Feng, Ellen Ngar Yun Poon, King Yiu Lee, Cheuk Kwong Lee, Chun Chen, Tak Yeung Leung, Margaret Heung Ling Ng, Ka Fai To, Han Wang, Hugh Simon Lam, Pak Cheung Ng, Patrick Man Pan Yuen, Karen Li, Alex Wing Kwan Leung, Chi Kong Li, Kam Tong Leung
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4380–4392.
https://doi.org/10.1182/bloodadvances.2020003307
Published: 2021
Includes: Supplemental data
Journal Articles

Role of lncRNA Morrbid in PTPN11 ( Shp2 ) E76K -driven juvenile myelomonocytic leukemia

Zhigang Cai, Chi Zhang, Jonathan J. Kotzin, Adam Williams, Jorge Henao-Mejia, Reuben Kapur
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3246–3251.
https://doi.org/10.1182/bloodadvances.2020002123
Published: 2020
Includes: Supplemental data
Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1615–1623.
https://doi.org/10.1182/bloodadvances.2020001728
Published: 2020